Company intelligence / Profile preview

SB China Venture Capital

Shanghai, China

Ownership: Private
Employees: ~50
Development stage: Other

Overview

SB China Venture Capital (SBCVC) is a prominent venture capital and private equity firm established in 2000 that manages both USD and RMB funds. The firm specializes in early and growth-stage investments, with a significant focus on the healthcare and life sciences sectors, alongside information technology and clean energy. SBCVC is recognized for its deep expertise in the Chinese biotech market, having backed industry leaders such as BGI Genomics and innovative startups like EdiGene. Headquartered in Shanghai, the firm provides strategic resources and global networking opportunities to its portfolio companies, leveraging its historical affiliation with the SoftBank Group.

Industry: Investors

Beyond the preview

Go deeper on SB China Venture Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SB China Venture Capital.

Explore the full profile